News and Trends 5 Oct 2022
Intravacc to develop intranasal gonorrhea vaccine with $14.6M NIH/NIAID contract
Intravacc has been awarded a contract with base and options that may total US$14.6 million for the development of a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). The contract has…